US pharmaceutical firm Eli Lilly says taking language, cultural diversity and site location into account helped boost ethnic minority participation in a recently completed trial.
Amrutanjan Health Care plans to add contract manufacturing and custom synthesis to services offered by loss making fine chemicals business, according to various reports.
Medical Photography is a potentially valuable yet underused resource in clinical trials according to Illingworth Research, which aims to increase its exposure with a new service.
The Russian Ministry of Health (MoH) has cleared nearly 600 trial sites for clinical research, easing concerns that the reaccreditation process was taking too long.
in-PharmaTechnologist presents its round-up of the latest in the world of drug delivery, including news from Sanofi Pasteur, Haselmeier, Unigene, and Southwest Research Institute.
The FDA is targeting companies that reformulate drugs to evade enforcement as it tries to crackdown on the 1000s of products marketed without approval.
Immunotherapy and vaccine specialist Circassia says its new license agreement with NanoPass Technologies will help its range of allergy products to thrive on the market.
SAFC announced its new aggressive growth strategy, including plans to expand in the developing markets, at its conference in Irvine, Glasgow last week.
Use of deoxycholate to chemically disrupt influenza viruses during vaccine manufacture could be linked to adverse reactions in children, a journal reports.
Mid-tier CROs are being squeezed out of the post-marketing sector as sponsors choose providers with more scale or specialisation, market research found.
Preclinical CRO Porsolt has opened a new research centre and laboratory space citing industry demand for large scale studies as the key driver for the investment.
International nutra and pharma contract manufacturing organisation, Catalent, has expanded its Italian operations and diversified its potential in vitamins, minerals and supplements.
Drug Developers struggle to find PK-PD providers that are fast and efficient says US CRO ClinPharm Consulting, after launching a new suite of services designed to cut risk and maximize return on R&D investment.
The FDA needs additional powers to update its “antiquated, domestically-focused statute” and end the “competitive advantage of non-compliance”, an agency official said.
in-PharmaTechnologist.com presents its round-up of the latest pharmaceutical industry appointments, including news from Okairos, Immunovaccine, and SteadyMed.
Australian preclinical services firm vivoPharma has opened a new vivarium and laboratory facility in the US as part of an effort to expand its global reach.
Albemarle says it will increase what it charges for generic APIs from next month, citing increasing regulatory and testing costs as the main reasons for the hike.
Pharma industry sponsors want more effective ways of measuring CRO performance according to the team behind a new project aiming to develop a validated set of analysis tools.
CRO performance across late stage, Phase I and central laboratories should improve in 2012 as strategic deals develop and smaller clients return, an analyst said.
Shares in drug discovery company Sareum have soared by 36 per cent after the firm announced the selection of a preclinical development candidate for its Checkpoint kinase 1 (Chk1) inhibitor programme.
Gerresheimer Regensburg GmbH has announced plans to increase production of its medical injection moulders four-fold in its China facility over the next 18 months.
Contract manufacturing organisation (CMO) Aurobindo Pharma has teamed up with Russian supplement maker OJSC Diod to establish a manufacturing joint-venture.
SGS Life Sciences has added cell-based bioassays to the range of services available at its Poitiers, France, facility in what it says is part of its new aggressive growth strategy.
Difficulties transferring know-how from US Pharmas to plants in Puerto Rico may be responsible for the high incidence of manufacturing quality problems on the island, according to the authors of a new study.